Current report
Open the filing on sec.gov
HCW Biologics Inc. (HCWB)
Nasdaq: HCWB · Pharmaceutical Preparations · Miramar, FL · filing with the SEC since 2020
The companyfiscal 2025, as filed
Revenue$54,232-97.9%
Net income-$8.0M+73.5%
Earnings per share$-10.63+65.7%
Operating cash flow-$13.4M+5.9%
Cash$2.0M-58.2%
Debt$0.00-100.0%
Shareholders’ equity$2.8M+140.8%
Shares, diluted2,097,701+116.3%
Return on equity-287.9%
The recordfrom its filings
Filings in 202676
Newest filingNov 5 · 8-K
Annual reportMar 31, 2026
Quarterly reportAug 14, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$500,000
Patents granted10
Filer category<br>Emerging growth company
Trailing twelve months to Jun 2026Revenue $6.7MNet income -$5.6MCash from operations -$12.1Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Registration effective
Open the filing on sec.gov
Private placement notice
Open the filing on sec.gov
Listing registration
Open the filing on sec.gov
Proxy statement
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Form PRER14A
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Preliminary proxy statement
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.